Cardiac Science Stock Sale Nets $20.8 Million
Cardiac Science Inc. said Tuesday that it raised about $20.8 million in a sale of stock to a group of U.S., Australian and Swiss institutional and private investors.
The Irvine developer of external cardiac defibrillator devices and software said the capital is in addition to $9.7 million it raised in June and ends the current financing round.
In the last two months, the company has received about $30.5 million in proceeds through the sale of 6.8 million shares at $4.50 a share.
Institutional investors participating in the latest financing included Domain Associates, Hunt Financial Corp. and the Pratt Group. The offering was led by de Greef & Co. Inc., an international financial advisory firm.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
